Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia - Concepedia

Concepedia

Publication | Open Access

Phase II Window Study on Rituximab in Newly Diagnosed Pediatric Mature B-Cell Non-Hodgkin's Lymphoma and Burkitt Leukemia

DOI Full Paper Access

186

Citations

26

References

2010

Year

Andrea Meinhardt, Birgit Burkhardt, Martin Zimmermann, Arndt Borkhardt, Udo Kontny, Thomas Klingebiel, Frank Berthold, Gritta Janka‐Schaub, Christoph Klein, Edita Kabíčková,

Journal of Clinical Oncology

Abstract

Rituximab is active as a single-agent in pediatric B-NHL even though the RR was lower than requested in the phase II plan.

References

	Year	Citations

Page 1